Tumours with higher PJA1 expression were infiltrated with fewer CD3+ cells, CD8+ T cells and CD11c+ DCs (Fig. 6c), indicating weaker antitumour immunity in the corresponding NPC patients. This evidence concerns the gene ITGAX and nasopharyngeal carcinoma.